These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31607396)

  • 1. Reply to Liang Sun and Yi Feng's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65: Importance of Surgical and Anesthesiological Standard Operating Procedures for Radical Cystectomy in a Bundled Care Setting.
    Vetterlein MW; Rink M
    Eur Urol; 2020 Jan; 77(1):e12-e13. PubMed ID: 31607396
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2019;77:55-65.
    Sun L; Feng Y
    Eur Urol; 2020 Jan; 77(1):e10-e11. PubMed ID: 31607395
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65.
    Montorsi F; Bandini M; Necchi A
    Eur Urol; 2020 Aug; 78(2):e75-e76. PubMed ID: 32362494
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55-65: Assessing the Morbidity of Multimodal Approaches in Patients with Muscle-invasive Bladder Cancer.
    Vetterlein MW; Gild P; Fisch M; Rink M
    Eur Urol; 2020 Aug; 78(2):e77-e78. PubMed ID: 32376138
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index.
    Vetterlein MW; Klemm J; Gild P; Bradtke M; Soave A; Dahlem R; Fisch M; Rink M
    Eur Urol; 2020 Jan; 77(1):55-65. PubMed ID: 31473012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to Marc A. Furrer and Patrick Y. Wuethrich's and Francesco Montorsi, Marco Moschini, Giorgio Gandaglia, and Alberto Briganti's Letters to the Editor re: Jakob Klemm, Michael Rink, Markus Von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005.
    Klemm J; Koelker M; Shariat SF; Fisch M; Vetterlein MW
    Eur Urol Focus; 2024 Jul; 10(4):674-675. PubMed ID: 37806850
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Francesco Montorsi, Giuseppe Rosiello, and Giorgio Gandaglia's Letter to the Editor re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
    Contieri R; Hensley PJ; Kamat AM
    Eur Urol Oncol; 2024 Apr; 7(2):301. PubMed ID: 37806840
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Jakob Klemm, Michael Rink, Markus von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005.
    Montorsi F; Moschini M; Gandaglia G; Briganti A
    Eur Urol Focus; 2024 Jul; 10(4):670. PubMed ID: 37748951
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Jakob Klemm, Michael Rink, Markus von Deimling, et al. Time-to-complication Patterns After Radical Cystectomy: A Secondary Analysis of a 30-day Morbidity Assessment Using the European Association of Urology Quality Criteria for Standardized Reporting. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.005.
    Furrer MA; Wuethrich PY
    Eur Urol Focus; 2024 Jul; 10(4):676-677. PubMed ID: 37806852
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Francesco Montorsi, Marco Bandini, Alberto Briganti, et al. Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations. Eur Urol 2020;78:489-91: Can Open and Robotic Radical Cystectomy be Considered Equally Effective in 2020?
    Witjes JA; Ribal MJ; van der Heijden AG
    Eur Urol; 2020 Oct; 78(4):492-493. PubMed ID: 32693931
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Samuel Bishara and Jim Adshead's letter to the editor re: Brian J. Linder, Igor Frank, John C. Cheville, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63:839-45.
    Linder BJ; Boorjian SA
    Eur Urol; 2013 Sep; 64(3):e49-50. PubMed ID: 23787355
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Siebren Dijkstra and Carl J. Wijburg's Letter to the Editor re: Bernard H. Bochner, Guido Dalbagni, Karim H. Marzouk, et al. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol 2018;74:465-71. Can the Pattern of Cancer Recurrence Truly be Assigned to the Surgical Modality?
    Bochner BH; Dalbagni G
    Eur Urol; 2019 May; 75(5):e138-e139. PubMed ID: 30712972
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Roberto Contieri, Patrick J. Hensley, Wei Shen Tan, et al. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non-muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy. Eur Urol Oncol. 2023;6:590-596.
    Montorsi F; Rosiello G; Gandaglia G
    Eur Urol Oncol; 2024 Apr; 7(2):300. PubMed ID: 37838554
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Satoru Taguchi, Tohru Nakagawa, and Hiroshi Fukuhara's Letter to the Editor re: Jürgen E. Gschwend, Matthias M. Heck, Jan Lehmann, et al. Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial. Eur Urol 2019;75:604-11.
    Gschwend JE; Heck M
    Eur Urol; 2019 Aug; 76(2):e37. PubMed ID: 31056229
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Francesco Montorsi, Marco Bandini, and Andrea Necchi's Letter to the Editor re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233-9.
    Soria F; D'Andrea D; Gontero P; Shariat SF
    Eur Urol Focus; 2022 Mar; 8(2):633-634. PubMed ID: 33875390
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Rui-Cheng Wu, Deng-Xiong Li, and De-Chao Feng's Letter to the Editor re: Michael Eppler, Conner Ganjavi, Lorenzo Storino Ramacciotti, et al. Awareness and Use of ChatGPT and Large Language Models: A Prospective Cross-sectional Global Survey in Urology. Eur Urol. 2024;85:146-53.
    Eppler M; Ganjavi C; Abreu A; Gill I; Cacciamani GE
    Eur Urol; 2024 Mar; 85(3):e85-e86. PubMed ID: 38182492
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Farshad Pourmalek, Hamidreza Abdi, and Peter C. Black's Letter to the Editor re: Daniel P. Nguyen, Bashir Al Hussein Al Awamlh, Xian Wu, et al. Recurrence Patterns After Open and Robot-assisted Radical Cystectomy for Bladder Cancer. Eur Urol 2015;68:399-405.
    Nguyen DP; Scherr DS
    Eur Urol; 2016 Mar; 69(3):e36. PubMed ID: 26187784
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Laurence Klotz's Letter to the Editor re: Jeremy Yeun-Chun Teoh, Daniele Castellani, Claudia Mercader, et al. A Quantitative Analysis Investigating the Prevalence of "Manels" in Major Urology Meetings. Eur Urol 2021;80:442-9. Eur Urol 2021;80:e100: Reply from the European Association of Urology Equity, Diversity, and Inclusion Task Force.
    Carmen Mir M; Greenwell T; O'Kelly F; Proietti S; Laukhtina E; Mertens L; Morgenstern S; Ouzaid I;
    Eur Urol; 2022 Jan; 81(1):e26-e27. PubMed ID: 34772550
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Jim C. Hu, Bilal Chughtai, Padraic O'Malley, et al. Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study. Eur Urol 2016;70:195-202: Comparative Effectiveness of Robotic-assisted versus Open Radical Cystectomy: Big Data but Meaningful Conclusions?
    Williams SB; Ghaffary CK; Dafashy TJ; Orihuela E
    Eur Urol; 2017 Jan; 71(1):e14-e15. PubMed ID: 27292866
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Pak et al.: Utilization Trends and Short-term Outcomes of Robotic Versus Open Radical Cystectomy for Bladder Cancer (Urology 2017;103:117-123) and Borza et al.: No Differences in Population-based Readmissions After Open and Robotic-assisted Cystectomy: Implications for Post-discharge Care (Urology 2017;104:77-83).
    Bjurlin MA; Huang WC
    Urology; 2017 Jul; 105():211. PubMed ID: 28450201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.